Development and external validation of a migraine analgesic usage (MAU) index for identifying high-severity migraine: A multi-center study.

This study aimed to create a scorecard for identifying severe migraines. It combines two factors: monthly acute medication days and a questionnaire about migraine treatment. Researchers wanted to see if this scorecard could effectively identify patients with a high migraine burden. The burden is defined as a score of 50 or more in four areas: monthly migraine days, acute medication days, pain intensity, and disability. The study involved over 1,100 adults with migraines from multiple centers in China. Participants had complete data for the necessary assessments. A logistic regression model was developed and tested for accuracy. The goal was to improve how clinicians assess and treat patients with severe migraines. This could lead to better management strategies and more effective treatment options for those suffering from debilitating migraine symptoms. The findings could enhance bedside decision-making for healthcare providers. Clinical relevance: This research provides a tool for clinicians to better identify patients with severe migraines, potentially leading to more effective treatment strategies tailored to individual needs.